1. O'Hanlon R, O'Shea P, Ledwidge M, et al. The biological variability of B-type natriuretic peptide and N-Terminal pro-B-type natriuretic peptide in stable heart failure patients. J Card Fail. In press.
2. Clinical deterioration in established heart failure: What is the value of BNP and weight gain in aiding diagnosis?;Lewin;Eur J Heart Failure,2005
3. European Medicines Agency. EPARs for authorised medicinal products for human use. Available from: http://www.emea.eu.int/humandocs/Humans/EPAR/lyrica/lyrica.htm. Accessed March 2, 2007.
4. US Food and Drug Administration. Lyrica Cv. Available from: http://www.fda.gov/cder/foi/label/2006/021446s002s003lbl.pdf. Accessed March 2, 2007.
5. Goodman & Gilman's the pharmacological basis of therapeutics,2006